BlackRock TCP Capital Corp. to Report Fourth Quarter Ended December 31, 2025 Financial Results on February 27, 2026
SANTA MONICA, Calif.–(BUSINESS WIRE)–BlackRock TCP Capital Corp. (NASDAQ: TCPC) announced today that it will report its financial results for the fourth... Read more.
CVR Energy Announces $1 Billion Private Placement of Senior Notes Due 2031 and Senior Notes Due 2034
SUGAR LAND, Texas–(BUSINESS WIRE)–CVR Energy, Inc. (the “Company” or “CVR Energy”) (NYSE: CVI) announced today that, subject to market conditions,... Read more.
Prepaid Cards Knowledge Center 2026: Online Business Intelligence Platform Offering Data, Analysis, and Opinion on Prepaid Cards – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Prepaid Cards Knowledge Center – Online Business Intelligence Platform Offering Data, Analysis, and Opinion on... Read more.
PublicSquare Appoints Dusty Wunderlich as Chief Executive Officer
New Leadership Reinforces Progress Toward Fintech Focus WEST PALM BEACH, Fla.–(BUSINESS WIRE)–PSQ Holdings, Inc. (NYSE: PSQH) (“PublicSquare”... Read more.
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
JERSEY CITY, N.J.–(BUSINESS WIRE)–Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its fourth... Read more.
Serial Entrepreneurs Behind Multiple Unicorns Raise $3.9M to Build AI Operating System for Electronics Procurement
DELHI, India–(BUSINESS WIRE)–#100Unicorns–1Buy.AI, an AI-first electronics procurement platform delivering 5–10% cost reductions within months... Read more.
Docebo Inc. Announces Substantial Issuer Bid, Preliminary Unaudited Fourth Quarter 2025 Financial Results and 2026 Guidance
TORONTO–(BUSINESS WIRE)–Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”), a leading learning platform provider with a foundation... Read more.
Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy
BLA Filing Based on HARMONi Global Phase III Study Results PDUFA Goal Action Date of November 14, 2026 Significant Unmet Need Remains; Over 14,000 U.S. Patients... Read more.
CVNA INVESTIGATION NEWS: Carvana Co. Short Seller Report Triggers Securities Fraud Investigation after Stock Drops Over 20% — Investors Notified to Contact BFA Law
NEW YORK–(BUSINESS WIRE)–$CVNA #BFA–Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Carvana Co. (NYSE:CVNA)... Read more.
Exact Imaging Reports Strong Momentum Driven by Commercial Execution and Clinical Validation in 2025
New sales model, expanded evidence base, NCCN guideline inclusion, and growing customer adoption reinforce the value of the ExactVu™ micro-ultrasound platform... Read more.